Generate a tailored SOP for Dr. Kareem Jamani. Improve your application with a focused, well-structured draft.
Dr. Kareem Jamani completed a bone marrow transplant and cellular therapy fellowship at the University of Calgary and the Fred Hutchinson Cancer Research Centre. He later obtained a Master of Public Health from Harvard Chan School of Public Health. Dr. Jamani is the director of the Alberta Blood & Marrow Transplant Program's adult long-term follow-up and survivorship clinic. His clinical practice focuses on leukemia and hematopoietic cell transplant (HCT)/cellular therapy, particularly pertaining to non-malignant diseases such as hemoglobinopathies and autoimmune diseases. Additionally, Dr. Jamani currently chairs the Cell Therapy Transplant Canada Donor & Collections Committee. His research as a clinical researcher emphasizes late effects, survivorship, and quality of life following hematopoietic cell transplant (HCT). His work has included examining the epidemiology of subsequent malignancies post-HCT, the spectrum of late toxicities associated with HCT, and their impact on the quality of life of both HCT recipients and caregivers. Dr. Jamani's additional research interests include the efficacy and toxicity of HCT cellular therapy for non-malignant diseases.
Cumming School of Medicine • Calgary, AB
Teaching and conducting research in hematology and transplant medicine.
Department of Computer Science Master's program. GRE scores are expected for international students.